U.S. FLASH PMI
US output growth slows to 18-month low as Omicron wave exacerbates supply delays and labor shortages
US private sector firms signalled a marked slowdown in growth at the start of 2022 amid softer demand conditions, worsening supply chain disruptions and labor shortages linked to the Omicron wave.
Adjusted for seasonal factors, the IHS Markit Flash US Composite PMI Output Index posted 50.8 in January, down notably from 57.0 in December. The resulting upturn in activity was only marginal, and the slowest since July 2020.
The slowdown in output growth was broad-based, with both manufacturing and service sector firms reporting near-stalled output as the steep spike in virus cases associated with the Omicron wave meant ongoing supply issues and labor shortages were exacerbated by renewed pandemic related containment measures.
Although output was constricted by the Omicron wave, demand growth remained more resilient. New orders for goods and services continued to rise strongly, albeit registering the weakest rise since December 2020. The upturn in new orders was supported by the service sector, as manufacturers stated that new sales growth was often held back by weaker demand from clients amid price rises and efforts to work through inventories. Renewed restrictions in key export markets and raw material shortages also led to a softer upturn in new export orders.
Meanwhile, input price inflation softened again in January. The rate of increase in costs was the slowest since last March, albeit sharper than any prior period in the series history. Firms noted that prices were driven up by greater supplier costs and upward pressure on wages. The pace of selling price inflation for goods and services picked up, and was the third-fastest on record (since October 2009) as companies sought to pass higher costs on to clients.
Despite challenging labor market conditions, firms were able to expand their workforce numbers in January. The rise in employment was only modest, however, with backlogs of work increasing solidly again. That said, the upturn in outstanding business was the slowest since March 2021 as some firms noted efforts to clear work-in-hand.
Although the degree of business confidence in the year ahead was the second-highest since last June, optimism waned. Concerns regarding further price rises and client responses to inflationary pressures weighed on expectations.
The seasonally adjusted IHS Markit Flash US Services PMI™ Business Activity Index fell to 50.9 in January, down from 57.6 in December. The expansion in business activity was only marginal overall, slowing notably from the previous survey period. Labor shortages, employee absences and the Omicron wave reportedly weighed on growth.
Demand conditions held relatively firm, however, as new business rose strongly. The rate of growth was the softest for four months, but was broadly in line with the series average. New business from abroad expanded for the third month running.
Input cost inflation slowed in January. The pace of increase was the joint-softest for almost a year despite being marked overall. Nonetheless, the uptick in costs was linked to supplier price hikes and soaring wage bills. Relatively firm demand conditions allowed companies to pass-through some input cost increases, as the rate of charge inflation accelerated to a series high.
Service providers increased their staffing numbers at a modest pace in an effort to relieve pressure on capacity. Although solid, the pace of growth in backlogs of work was the slowest since May 2021.
Business confidence was dampened in January and slipped to a three-month low amid concerns regarding the impact of inflation and the pandemic on demand over the coming months.
The health of the manufacturing sector improved to the least marked extent since October 2020 in January, as highlighted by the IHS Markit Flash US Manufacturing Purchasing Managers’ Index™ (PMI™)posting at 55.0, down from 57.7 in December. Again, the headline figure was supported by a greater deterioration in vendor performance which would ordinarily be a signal of improving operating conditions. That said, supply chain issues abounded, which further hampered production and weighed on client demand.
Output levels were broadly unchanged from those seen in December, as new order growth slowed to the softest rate since July 2020. Alongside labor and material shortages stymieing the upturn, firms noted that customers were keen to reduce spending amid sharp hikes in costs.
The rate of cost inflation eased again in January and was the slowest since May 2021. Although still marked overall, there were signs of pressure waning. Similarly, the pace of charge inflation softened and was the least marked since April 2021.
In line with softer demand conditions, firms signalled slower upturns in input buying and stock building. Rates of growth were the slowest since February and March 2021, respectively.
Labor shortages, a high turnover of staff and reports of the non-replacement of voluntary leavers led to the first decline in manufacturing employment since July 2020. Despite backlogs of work rising again, the expansion was the softest since last February.
Finally, manufacturers bucked the trend and signalled stronger optimism regarding future output in January. Confidence was the highest since November 2020 amid hopes of stable supply flows and a reduction in the impact of COVID-19.
The key stuff:
- “Output levels were broadly unchanged from those seen in December”. From the December PMI: “With the exception of October and November, the pace of output growth was the slowest since October 2020.” That is 4 months of pretty weak growth, if any, in manufacturing production.
- “[Manufacturing] new order growth slowed to the softest rate since July 2020.” From the December PMI: “new orders
expanded at the softest rate for a year.” Production is weak and new orders are weak. Bad! - “firms noted that customers were keen to reduce spending amid sharp hikes in costs.” The problem is more than demand, customers need to cut spending because their margins are declining.
- “efforts to work through inventories.” We know these are too high, so the lull will last for a little while.
- Service providers, whose new business rose strongly, talk of soaring wage bills with charge inflation accelerating to a series high. Last month: “soaring wage bills and greater supplier prices led to the steepest increase in cost burdens on record.” Forget Goods inflation. The problem is services prices and wages.
- “the rise in [services] employment was only modest” and January saw the “first decline in manufacturing employment since July 2020”.
Transitory stagflation Mr. Powell? He’s better be right on that if he starts hiking in March.
But will he?
Slow employment growth, reduced hours and rising prices are nothing to boost consumer spending.
“For all the spending of all types through January 17, 2022, we have seen it up over 11% versus the start of ’21, which is well up over ’20 and ’19.” – Bank of America (BAC) CEO Brian Moynihan
Hmmm…Chase’s data is not quite as strong through Jan. 17. At least, it’s not getting worse.
The Chicago Fed National Activity Index (CFNAI) dropped to -0.15 during December from 0.44 in November, revised from 0.37. In 2021, the index improved to 0.33 from -0.48 in 2020.
The index’s three-month moving average eased in December to 0.33 from 0.40. During the last 10 years, there has been an 75% correlation between the change in the Chicago Fed Index and quarterly growth in real GDP.
The Personal Consumption & Housing component moved lower to -0.19 from -0.02 in November. The Production & Income component weakened to -0.13 from 0.25 in November. The Employment, Unemployment & Hours component eased to 0.13 from 0.16. The Sales, Orders & Inventories index slipped to 0.03 from 0.05 in November.
The CFNAI diffusion index, which measures the breadth of movement in the component series, fell to 0.37 in December from 0.42 in November. The diffusion index averaged 0.28 in 2021, up from 0.19 in 2020.
Retail investors bought $1.36 bln in stocks on Jan 24 That is the highest level since Jan. 18 when net purchases exceeded $1.6 billion in stocks, according to Vanda, and indicates that retail traders continue to buy on market dips.
Nasdaq Composite’s Wild Swing Precursor to Bounce, History Shows
The Nasdaq Composite Index’s gain on Monday after an intraday plunge of nearly 5% was only the sixth time this century that a swing of that magnitude occurred. Each instance led to a rather sharp recovery within the prevailing downtrend.
Trading data analyzed by Bloomberg shows that in the other five sessions since 2000 that saw the Nasdaq Composite close in the green after reversing a drop exceeding 4%, the decline came to a stall and a sharp rally ensued for a few days to a few weeks. (…)
Excluding the latest occurrence, the Nasdaq Composite was up an average of 3.5% after five days — with the index also higher in all five instances. The mean gain after 20 days widened to 5.2%, with the benchmark higher in four of five cases. (…)
John Authers: Boomerang Rally Hints at Deeper Market Troubles History suggests that such dramatic reversals happen only when something is amiss.
(…) Trading reversals this dramatic are not common. Bespoke Investment Group finds only five prior instances since its records began when the Nasdaq Composite fell as much as 4% intraday and finished in positive territory. Here they are, with Bespoke’s detail on what happened next. (…)
Investors Lose Appetite for Stocks of Unprofitable Companies The prospect of rising interest rates has been especially hard on the Russell 2000 small-cap index, in large part because of the high proportion of small-caps that aren’t making money.
(…) Companies making up 31% of the Russell 2000 were unprofitable as of the end of 2021, according to an analysis from Jefferies of earnings over the previous 12 months. By contrast, 5.7% of the Russell 1000 index of larger firms was made up of companies without earnings. (…) Within the Russell 2000, shares of companies without earnings have fallen further this year than has the index as a whole, according to Mr. DeSanctis. (…)
Chinese state-owned property firms step in to rescue cash-strapped developers
(…) “For sure we will see more of these deals, because the central government has made the order,” said Oscar Choi, founder and CIO of Oscar and Partners Capital Limited. “Large state-owned enterprises will need to respond and act.”
Choi expects SOEs will not go beyond assets and management property business to directly acquire stakes in the distressed developers, as Beijing wants to stop short of direct bailouts and keep only the “meaningful” players in the market.
“Equity investment will be a last resort … (Beijing’s) broad principle is save the market and not individual developers.” (…)
COVID-19
State of Affairs: Jan 24 Katelyn Jetelina
(…) Over the weekend, we reached an important milestone in South Africa—Omicron’s epicenter—as all indicators peaked. We were waiting for deaths to peak, which happened at 20% of Delta’s peak. Today, their test positivity rate is below 10%, indicating that transmission is largely under control for now.
But case patterns across the globe may change soon. That’s because a new sub-variant is taking hold: BA.2. Late last year, Omicron (called BA.1) mutated into a sister lineage. This new version of Omicron has many of the same mutations as BA.1 but has a lot of differences, too. (…) BA.2 has ~85 mutations while BA.1 has ~60 mutations. Usually it takes a while for this many mutations to arise, but it didn’t this time. Could this be due to animal reservoirs? In other words, is this mutation a result of the virus jumping from humans to animals and back to humans? Maybe, we don’t know.
Importantly, BA.2 lacks the spike mutations Δ69-70. This is important, because it means, unlike with BA.1, BA.2 doesn’t have a special signal on PCR tests to tell labs that it is Omicron. All tests now need to go to genetic sequencing for variant identification. This is why the Guardian coined it the “stealth” version of Omicron a month ago.
On Friday, the U.K. labeled BA.2 a “Variant Under Investigation (VUI),” as it’s doubling every 4 days there which equates to a 120% growth advantage over BA.1. VUI is the least severe variant classification, but still a signal that we need to pay attention. BA.2 has already started to take hold in places like India, Philippines, Netherlands, France, and Denmark. (…)
There’s a lot we don’t know about this variant, but we have a few clues so far:
Transmissibility: The consistency of BA.2 growth across several counties means that it’s more transmissible than BA.1. It’s likely nothing like the huge transmissibility jump we saw from Delta to Omicron, though (500% growth advantage). This means that Omicron waves will likely be drawn out (like we are seeing in Denmark or France). In places like the United States, we may see two peaks for the same wave. This won’t be a massive wave on top of another massive wave, though. It’s still Omicron.
Severity: Early data from Denmark shows there’s no disease severity difference between BA.1 and BA.2.
Immunity: There is likely to be minimal differences in vaccine effectiveness in BA.2 compared to BA.1. In other words, our boosters will still work very well. It is also very likely that there will be cross-reactivity: BA.1 infection will protect against BA.2 infection.
We know this virus will mutate. And BA.2 is an example that it’s doing what we expect. We should keep an eye on this, but I’m not too concerned right now. I’m more concerned about another variant popping out of nowhere like Omicron did.
Cases in the United States have largely plateaued at 690,448 cases per day (208 cases per 100,000), with a modest 2% increase over the past 2 weeks. The Northeast has clearly peaked, with cases plummeting in New Jersey (–64% 14-day case change), Washington DC (–61%), New York (–58%), and Maryland (–54%). This is offset by growth in Oklahoma (+196%), Idaho (+174%), Alaska (+164%), and Wyoming (+141%).
Cases by Region, last 90 days (NYT)
As Dr. Trevor Bedford, a brilliant computational epidemiologist and scientist, pointed out, these epidemics across states have proceeded in a strikingly similar fashion and most states seem to be on the same curve. Some are just farther a head on this curve than others. Dr. Bedford estimated that as of January 17, 4.5% of the U.S. population recorded a confirmed case. After accounting for under-reporting, we should expect 36-46% of the U.S. population to have been infected by Omicron by mid-February. This is just astounding for a virus to achieve in a short 8 weeks.
Hospitalizations in the United States have increased 24% over the past two weeks, and we currently have 158,825 people hospitalized. There are preliminary indications that hospitalizations have begun to plateau, though. And hospitalizations continue to be largely among unvaccinated people. In fact, this weekend in New York City hospitalizations among unvaccinated people were literally off the chart.
(New York City)
Thankfully, CDC finally updated their data and, on a national level, the relationship couldn’t be more clear: In December, compared to fully vaccinated persons, the monthly rates of COVID-19-associated hospitalizations were 16 times higher in unvaccinated adults.
Age-Adjusted Rates of COVID-19-Associated Hospitalizations by Vaccination Status in Adults Ages ≥18 Years, January–December 2021 (CDC)
Deaths have increased 41% in the past 2 weeks. For the first time since February 2021, we reported 3,896 COVID19 deaths in the United States. This made last Friday the 10th deadliest day of the whole pandemic and the deadliest since vaccines were widely available to Americans. We are loosing more Americans each day to COVID19 than we did during 9/11. And the biggest tragedy is that COVID19 death is preventable— vaccines reduce the risk of dying by 68 times. Omicron may be milder compared to Delta, but it’s not mild.
(Newsnodes with labels by Jetelina)
Taken together, this probably explains why the majority of Americans see the COVID19 situation as “getting a lot” worse lately.
(Gallup)
Bottom Line
: The Omicron wave is peaking across much of the globe, but this may be drawn out due to a new sister mutation called BA.2. As expected, hospitalizations and deaths are closely following. Hang in there, it will get better.
So, South Africa’s deaths are peaking at 20% of Delta’s peak. In the USA:
Data: Our World in Data. Chart: Will Chase/Axios